These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26675672)

  • 1. Human parainfluenza virus type 2 V protein inhibits and antagonizes tetherin.
    Ohta K; Goto H; Yumine N; Nishio M
    J Gen Virol; 2016 Mar; 97(3):561-570. PubMed ID: 26675672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human parainfluenza virus type 2 V protein inhibits induction of tetherin.
    Ohta K; Matsumoto Y; Yumine N; Nishio M
    Med Microbiol Immunol; 2017 Aug; 206(4):311-318. PubMed ID: 28455649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetherin antagonism by V proteins is a common trait among the genus Rubulavirus.
    Ohta K; Matsumoto Y; Ito M; Nishio M
    Med Microbiol Immunol; 2017 Aug; 206(4):319-326. PubMed ID: 28466381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction.
    Le Tortorec A; Willey S; Neil SJ
    Viruses; 2011 May; 3(5):520-40. PubMed ID: 21994744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetherin restricts herpes simplex virus 1 and is antagonized by glycoprotein M.
    Blondeau C; Pelchen-Matthews A; Mlcochova P; Marsh M; Milne RS; Towers GJ
    J Virol; 2013 Dec; 87(24):13124-33. PubMed ID: 24067975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus 1 counteracts tetherin restriction via its virion host shutoff activity.
    Zenner HL; Mauricio R; Banting G; Crump CM
    J Virol; 2013 Dec; 87(24):13115-23. PubMed ID: 24067977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Vpu Antagonizes CD317/Tetherin by Adaptor Protein-1-Mediated Exclusion from Virus Assembly Sites.
    Pujol FM; Laketa V; Schmidt F; Mukenhirn M; Müller B; Boulant S; Grimm D; Keppler OT; Fackler OT
    J Virol; 2016 Aug; 90(15):6709-6723. PubMed ID: 27170757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profilin2 is required for filamentous actin formation induced by human parainfluenza virus type 2.
    Ohta K; Matsumoto Y; Nishio M
    Virology; 2019 Jul; 533():108-114. PubMed ID: 31150988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants in HIV-2 Env and tetherin required for functional interaction.
    Exline CM; Yang SJ; Haworth KG; Rengarajan S; Lopez LA; Droniou ME; Seclen E; Cannon PM
    Retrovirology; 2015 Aug; 12():67. PubMed ID: 26248668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human parainfluenza virus type 2 V protein inhibits caspase-1.
    Ohta K; Matsumoto Y; Nishio M
    J Gen Virol; 2018 Apr; 99(4):501-511. PubMed ID: 29485395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetherin inhibits prototypic foamy virus release.
    Xu F; Tan J; Liu R; Xu D; Li Y; Geng Y; Liang C; Qiao W
    Virol J; 2011 May; 8():198. PubMed ID: 21529378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-terminal hydrophobic region in human bone marrow stromal cell antigen 2 (BST-2)/tetherin protein functions as second transmembrane motif.
    Andrew AJ; Kao S; Strebel K
    J Biol Chem; 2011 Nov; 286(46):39967-81. PubMed ID: 21937450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of eukaryotic tetherin/Vpu proteins and detection of their interaction by ELISA.
    Lv M; Zhu Y; Wang J; Zhang H; Wang X; Zuo T; Liu D; Zhang J; Wu J; Kong W; Yu X
    Protein Expr Purif; 2013 Oct; 91(2):112-8. PubMed ID: 23916489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetherin and its viral antagonists.
    Kuhl BD; Cheng V; Wainberg MA; Liang C
    J Neuroimmune Pharmacol; 2011 Jun; 6(2):188-201. PubMed ID: 21222046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of inactive tetherin delGPI mutant inhibits HIV-1 Vpu-mediated antagonism of endogenous tetherin.
    Lv M; Wang J; Zhu Y; Wang X; Zuo T; Liu D; Zhang J; Wu J; Zhang H; Kong W; Yu X
    FEBS Lett; 2013 Jan; 587(1):37-43. PubMed ID: 23201263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of the host restriction factor tetherin in viral immune sensing.
    Hotter D; Sauter D; Kirchhoff F
    J Mol Biol; 2013 Dec; 425(24):4956-64. PubMed ID: 24075872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies.
    Brinkmann C; Nehlmeier I; Walendy-Gnirß K; Nehls J; González Hernández M; Hoffmann M; Qiu X; Takada A; Schindler M; Pöhlmann S
    J Virol; 2016 Dec; 90(24):11075-11086. PubMed ID: 27707924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza virus is not restricted by tetherin whereas influenza VLP production is restricted by tetherin.
    Watanabe R; Leser GP; Lamb RA
    Virology; 2011 Aug; 417(1):50-6. PubMed ID: 21621240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmembrane interactions of HIV-1 Vpu and tetherin.
    Guo F; Liang C
    Curr HIV Res; 2012 Jun; 10(4):292-7. PubMed ID: 22524177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 Vpu's lipid raft association is dispensable for counteraction of the particle release restriction imposed by CD317/Tetherin.
    Fritz JV; Tibroni N; Keppler OT; Fackler OT
    Virology; 2012 Mar; 424(1):33-44. PubMed ID: 22222210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.